SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,781.89 -251.89
( -0.34%)

Global Indices

Nasdaq

51,707.15 -164.40
(-0.32%)

Dow Jones

7,828.98 0.74
(0.01%)

Hang Seng

67,780.30 2.78
(0.00%)

Nikkei 225

10,649.29 -6.99
(-0.07%)

Forex

USD-INR

95.69 -0.76
(-0.79%)

EUR-INR

107.00 -1.04
(-0.96%)

GBP-INR

126.57 -1.05
(-0.82%)

JPY-INR

0.60 -0.01
(-0.89%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3851573

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

20.75

157.62

EPS(TTM)

Face Value()

Div & Yield %

4.77

1.21

Back

Gokaldas Exports consolidated net profit rises 6.82% in the June 2026 quarter

Aug 12,2026

Net profit of Gokaldas Exports rose 6.82% to Rs 44.30 crore in the quarter ended June 2026 as against Rs 41.47 crore during the previous quarter ended June 2025. Sales rose 20.69% to Rs 1153.51 crore in the quarter ended June 2026 as against Rs 955.79 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1153.51	955.79	21
OPM %	9.75	10.18	-
PBDT	108.64	96.18	13
PBT	62.83	56.81	11
NP	44.30	41.47	7

72,781.89 -251.89 ( -0.34%)

51,707.15 -164.40 (-0.32%)

7,828.98 0.74 (0.01%)

67,780.30 2.78 (0.00%)

10,649.29 -6.99 (-0.07%)

95.69 -0.76 (-0.79%)

107.00 -1.04 (-0.96%)

126.57 -1.05 (-0.82%)

0.60 -0.01 (-0.89%)